4D Pharma to Present at Upcoming Investor Conferences in March

Author's Avatar
Mar 03, 2021
Article's Main Image

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announced that 4D management will present at three upcoming investor conferences: